Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma

被引:58
作者
Camisasca, Danielle Resende [1 ]
Honorato, Julia [1 ]
Bernardo, Vagner [1 ]
da Silva, Licinio Esmeraldo [2 ]
da Fonseca, Eliene Carvalho [3 ]
Silvestre de Faria, Paulo Antonio [4 ]
Dias, Fernando Luiz [5 ]
Chaves Lourenco, Simone de Queiroz [1 ]
机构
[1] Univ Fed Fluminense, Pathol Grad Program, BR-24030210 Niteroi, RJ, Brazil
[2] Univ Fed Fluminense, Dept Stat, Math Inst, BR-24020140 Niteroi, RJ, Brazil
[3] Univ Fed Fluminense, Dept Pathol, Sch Med, Hosp Univ Antonio Pedro, BR-24033900 Niteroi, RJ, Brazil
[4] Natl Canc Inst, Div Pathol, BR-20220400 Rio De Janeiro, Brazil
[5] Natl Canc Inst, Dept Head & Neck Surg, BR-20230130 Rio De Janeiro, Brazil
关键词
Mouth neoplasms; Squamous cell carcinoma; Prognosis; Survival analysis; Immunohistochemistry; Bcl-2-associated X protein; C-Bcl-2; proteins; Bcl-X protein; IN-VIVO; BAX; HEAD; CANCER; NECK; P53; TONGUE;
D O I
10.1016/j.oraloncology.2008.05.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aims of this study were to assess the expression levels of three proteins involved in apoptosis-Bcl-2, Bcl-X, and Bax-and evaluate their relationship with clinicopathologic features and survival in oral squamous cell carcinoma (OSCC). Immunohistochemistry was used to evaluate protein expression in 53 primary OSCCs treated by radical surgery with free margins at a single institution in 1999. Histologic specimens were graded and analyzed for perineural invasion, lymphocytic infiltrate, and pattern of invasion. Digital image analysis was performed to quantify immunostaining. Survival was analyzed using the Kaplan-Meier method and Cox's proportional hazard model. Cancer-specific 5-year survival (CSS) was 61% (56% overall survival (OS), and 51% disease-free interval (DFI)). Kaplan-Meier analysis identified pathologic stage (p = 0.0007 log-rank test, OS), negative nodes status (pN) (p < 0.0001, log-rank test, OS), presence of lymphocytic infiltrate (p = 0.0084, log-rank test, OS), and high Bax expression (p = 0.025, log-rank test, OS) to each be associated with both better OS and CSS. Tongue tumors (p=0.0179, log-rank test), worst pattern of invasion (p = 0.0293, log-rank test), lack of lymphocytic infiltrate (p = 0.0328, log-rank test), perineural invasion (p = 0.0448, log-rank test), poorly differentiated tumors (p = 0.0318, log-rank test), and low Bcl-X expression (p = 0.044, log-rank test) were all associated with a low DFI. Cox regression found pN, lymphocytic infiltrate, and Bax expression to be independent prognostic factors for OS and CSS, whereas lymphocytic response and tongue tumors were predictors of DFI. Bcl-2 expression emerged as an independent marker of favorable CSS. Lymphocytic infiltrate was the most meaningful histopathologic parameter in survival analysis, whereas expression of Bcl-2 family members seems to be an important marker of a favorable prognosis in OSCC. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 31 条
[21]  
2-Q
[22]   Bcl-2 expression in oral squamous cell carcinoma [J].
Popovic, B. ;
Jekic, B. ;
Novakovic, I. ;
Lukovic, L. J. ;
Tepavcevic, Z. ;
Jurisic, V. ;
Vukadinovic, M. ;
Milasin, J. .
SIGNAL TRANSDUCTION PATHWAYS, PT C: CELL SIGNALING IN HEALTH AND DISEASE, 2007, 1095 :19-25
[23]   Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma:: Relationships with prognosis [J].
Sampaio-Góes, FCG ;
Oliveira, DT ;
Dorta, RG ;
Nonogaki, S ;
Landman, G ;
Nishimoto, IN ;
Kowalski, LP .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (11) :982-989
[24]  
Stewart KleihuesP., 2003, World Cancer Report
[25]  
Teni Tanuja, 2002, Pathology and Oncology Research, V8, P109
[26]   Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx [J].
Veneroni, S ;
Silvestrini, R ;
Costa, A ;
Salvatori, P ;
Faranda, A ;
Molinari, R .
ORAL ONCOLOGY, 1997, 33 (06) :408-413
[27]   bcl-2 expression in head and neck cancer:: An enigmatic prognostic marker [J].
Wilson, GD ;
Saunders, MI ;
Dische, S ;
Richman, PI ;
Daley, FM ;
Bentzen, SM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (02) :435-441
[28]   Pathology of the N0 neck [J].
Woolgar, JA .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 1999, 37 (03) :205-209
[29]   Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma [J].
Woolgar, JA .
ORAL ONCOLOGY, 2006, 42 (03) :229-239
[30]  
Xie X, 1999, CANCER-AM CANCER SOC, V86, P913, DOI 10.1002/(SICI)1097-0142(19990915)86:6<913::AID-CNCR4>3.0.CO